Telemedicine for Diabetes Care in India during COVID19 Pandemic and National Lockdown Period: Guidelines for Physicians
Identifieur interne : 000110 ( Pmc/Checkpoint ); précédent : 000109; suivant : 000111Telemedicine for Diabetes Care in India during COVID19 Pandemic and National Lockdown Period: Guidelines for Physicians
Auteurs : Amerta Ghosh [Inde] ; Ritesh Gupta [Inde] ; Anoop Misra [Inde]Source :
- Diabetes & Metabolic Syndrome [ 1871-4021 ] ; 2020.
Abstract
In view of restrictions on mobility of patients because of COVID-19 pandemic, face-to-face consultations are difficult. We sought to study the feasibility of telemedicine in this scenario.
PubMed database and Google Scholar were searched using the key terms ‘telemedicine’, ‘diabetes’, ‘COVID-19’up to 31ST March 2020. In addition, existing guidelines including those by Ministry of Health and Family Welfare (MOHFW), Government of India were accessed.
We discuss evidence and general guidelines regarding role of telemedicine in patients with diabetes along with its utility and limitations.
Telemedicine is a useful tool for managing patients of diabetes during this lockdown period. However, there is limited data and further research is required.
Url:
DOI: 10.1016/j.dsx.2020.04.001
PubMed: 32283497
PubMed Central: 7129346
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
PMC:7129346Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Telemedicine for Diabetes Care in India during COVID19 Pandemic and National Lockdown Period: Guidelines for Physicians</title>
<author><name sortKey="Ghosh, Amerta" sort="Ghosh, Amerta" uniqKey="Ghosh A" first="Amerta" last="Ghosh">Amerta Ghosh</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">Fortis CDOC Hospital for Diabetes and Allied Specialties, Chirag Enclave, New Delhi, India</nlm:aff>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Fortis CDOC Hospital for Diabetes and Allied Specialties, Chirag Enclave, New Delhi</wicri:regionArea>
<wicri:noRegion>New Delhi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gupta, Ritesh" sort="Gupta, Ritesh" uniqKey="Gupta R" first="Ritesh" last="Gupta">Ritesh Gupta</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">Fortis CDOC Hospital for Diabetes and Allied Specialties, Chirag Enclave, New Delhi, India</nlm:aff>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Fortis CDOC Hospital for Diabetes and Allied Specialties, Chirag Enclave, New Delhi</wicri:regionArea>
<wicri:noRegion>New Delhi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Misra, Anoop" sort="Misra, Anoop" uniqKey="Misra A" first="Anoop" last="Misra">Anoop Misra</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">Fortis CDOC Hospital for Diabetes and Allied Specialties, Chirag Enclave, New Delhi, India</nlm:aff>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Fortis CDOC Hospital for Diabetes and Allied Specialties, Chirag Enclave, New Delhi</wicri:regionArea>
<wicri:noRegion>New Delhi</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff2">National Diabetes, Obesity and Cholesterol Foundation, New Delhi, India</nlm:aff>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>National Diabetes, Obesity and Cholesterol Foundation, New Delhi</wicri:regionArea>
<wicri:noRegion>New Delhi</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff3">Diabetes Foundation (India), New Delhi, India</nlm:aff>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Diabetes Foundation (India), New Delhi</wicri:regionArea>
<wicri:noRegion>New Delhi</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">32283497</idno>
<idno type="pmc">7129346</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129346</idno>
<idno type="RBID">PMC:7129346</idno>
<idno type="doi">10.1016/j.dsx.2020.04.001</idno>
<date when="2020">2020</date>
<idno type="wicri:Area/Pmc/Corpus">000642</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000642</idno>
<idno type="wicri:Area/Pmc/Curation">000642</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000642</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000110</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000110</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Telemedicine for Diabetes Care in India during COVID19 Pandemic and National Lockdown Period: Guidelines for Physicians</title>
<author><name sortKey="Ghosh, Amerta" sort="Ghosh, Amerta" uniqKey="Ghosh A" first="Amerta" last="Ghosh">Amerta Ghosh</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">Fortis CDOC Hospital for Diabetes and Allied Specialties, Chirag Enclave, New Delhi, India</nlm:aff>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Fortis CDOC Hospital for Diabetes and Allied Specialties, Chirag Enclave, New Delhi</wicri:regionArea>
<wicri:noRegion>New Delhi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gupta, Ritesh" sort="Gupta, Ritesh" uniqKey="Gupta R" first="Ritesh" last="Gupta">Ritesh Gupta</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">Fortis CDOC Hospital for Diabetes and Allied Specialties, Chirag Enclave, New Delhi, India</nlm:aff>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Fortis CDOC Hospital for Diabetes and Allied Specialties, Chirag Enclave, New Delhi</wicri:regionArea>
<wicri:noRegion>New Delhi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Misra, Anoop" sort="Misra, Anoop" uniqKey="Misra A" first="Anoop" last="Misra">Anoop Misra</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">Fortis CDOC Hospital for Diabetes and Allied Specialties, Chirag Enclave, New Delhi, India</nlm:aff>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Fortis CDOC Hospital for Diabetes and Allied Specialties, Chirag Enclave, New Delhi</wicri:regionArea>
<wicri:noRegion>New Delhi</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff2">National Diabetes, Obesity and Cholesterol Foundation, New Delhi, India</nlm:aff>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>National Diabetes, Obesity and Cholesterol Foundation, New Delhi</wicri:regionArea>
<wicri:noRegion>New Delhi</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff3">Diabetes Foundation (India), New Delhi, India</nlm:aff>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Diabetes Foundation (India), New Delhi</wicri:regionArea>
<wicri:noRegion>New Delhi</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Diabetes & Metabolic Syndrome</title>
<idno type="ISSN">1871-4021</idno>
<idno type="eISSN">1878-0334</idno>
<imprint><date when="2020">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec><title>Background and Aims</title>
<p>In view of restrictions on mobility of patients because of COVID-19 pandemic, face-to-face consultations are difficult. We sought to study the feasibility of telemedicine in this scenario.</p>
</sec>
<sec><title>Methods</title>
<p>PubMed database and Google Scholar were searched using the key terms ‘telemedicine’, ‘diabetes’, ‘COVID-19’up to 31<sup>ST</sup>
March 2020. In addition, existing guidelines including those by Ministry of Health and Family Welfare (MOHFW), Government of India were accessed.</p>
</sec>
<sec><title>Results</title>
<p>We discuss evidence and general guidelines regarding role of telemedicine in patients with diabetes along with its utility and limitations.</p>
</sec>
<sec><title>Conclusions</title>
<p>Telemedicine is a useful tool for managing patients of diabetes during this lockdown period. However, there is limited data and further research is required.</p>
</sec>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Onder, G" uniqKey="Onder G">G. Onder</name>
</author>
<author><name sortKey="Rezza, G" uniqKey="Rezza G">G. Rezza</name>
</author>
<author><name sortKey="Brusaferro, S" uniqKey="Brusaferro S">S. Brusaferro</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Gupta, R" uniqKey="Gupta R">R. Gupta</name>
</author>
<author><name sortKey="Ghosh, A" uniqKey="Ghosh A">A. Ghosh</name>
</author>
<author><name sortKey="Singh, A K" uniqKey="Singh A">A.K. Singh</name>
</author>
<author><name sortKey="Misra, A" uniqKey="Misra A">A. Misra</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Sudhamony, S" uniqKey="Sudhamony S">S. Sudhamony</name>
</author>
<author><name sortKey="Nandakumar, K" uniqKey="Nandakumar K">K. Nandakumar</name>
</author>
<author><name sortKey="Binu, P" uniqKey="Binu P">P. Binu</name>
</author>
<author><name sortKey="Niwas, S I" uniqKey="Niwas S">S.I. Niwas</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Mehta, K G" uniqKey="Mehta K">K.G. Mehta</name>
</author>
<author><name sortKey="Chavda, P" uniqKey="Chavda P">P. Chavda</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Zhai, Y K" uniqKey="Zhai Y">Y.K. Zhai</name>
</author>
<author><name sortKey="Zhu, W J" uniqKey="Zhu W">W.J. Zhu</name>
</author>
<author><name sortKey="Cai, Y L" uniqKey="Cai Y">Y.L. Cai</name>
</author>
<author><name sortKey="Sun, D X" uniqKey="Sun D">D.X. Sun</name>
</author>
<author><name sortKey="Zhao, J" uniqKey="Zhao J">J. Zhao</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Flodgren, G" uniqKey="Flodgren G">G. Flodgren</name>
</author>
<author><name sortKey="Rachas, A" uniqKey="Rachas A">A. Rachas</name>
</author>
<author><name sortKey="Farmer, A J" uniqKey="Farmer A">A.J. Farmer</name>
</author>
<author><name sortKey="Inzitari, M" uniqKey="Inzitari M">M. Inzitari</name>
</author>
<author><name sortKey="Shepperd, S" uniqKey="Shepperd S">S. Shepperd</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Timpel, P" uniqKey="Timpel P">P. Timpel</name>
</author>
<author><name sortKey="Oswald, S" uniqKey="Oswald S">S. Oswald</name>
</author>
<author><name sortKey="Schwarz, P E H" uniqKey="Schwarz P">P.E.H. Schwarz</name>
</author>
<author><name sortKey="Harst, L" uniqKey="Harst L">L. Harst</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Gopalan, H S" uniqKey="Gopalan H">H.S. Gopalan</name>
</author>
<author><name sortKey="Haque, I" uniqKey="Haque I">I. Haque</name>
</author>
<author><name sortKey="Ahmad, S" uniqKey="Ahmad S">S. Ahmad</name>
</author>
<author><name sortKey="Gaur, A" uniqKey="Gaur A">A. Gaur</name>
</author>
<author><name sortKey="Misra, A" uniqKey="Misra A">A. Misra</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Diabetes Metab Syndr</journal-id>
<journal-id journal-id-type="iso-abbrev">Diabetes Metab Syndr</journal-id>
<journal-title-group><journal-title>Diabetes & Metabolic Syndrome</journal-title>
</journal-title-group>
<issn pub-type="ppub">1871-4021</issn>
<issn pub-type="epub">1878-0334</issn>
<publisher><publisher-name>Published by Elsevier Ltd on behalf of Diabetes India.</publisher-name>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">32283497</article-id>
<article-id pub-id-type="pmc">7129346</article-id>
<article-id pub-id-type="publisher-id">S1871-4021(20)30060-6</article-id>
<article-id pub-id-type="doi">10.1016/j.dsx.2020.04.001</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Telemedicine for Diabetes Care in India during COVID19 Pandemic and National Lockdown Period: Guidelines for Physicians</article-title>
</title-group>
<contrib-group><contrib contrib-type="author" id="au1"><name><surname>Ghosh</surname>
<given-names>Amerta</given-names>
</name>
<xref rid="aff1" ref-type="aff">a</xref>
</contrib>
<contrib contrib-type="author" id="au2"><name><surname>Gupta</surname>
<given-names>Ritesh</given-names>
</name>
<xref rid="aff1" ref-type="aff">a</xref>
</contrib>
<contrib contrib-type="author" id="au3"><name><surname>Misra</surname>
<given-names>Anoop</given-names>
</name>
<email>anoopmisra@gmail.com</email>
<xref rid="aff1" ref-type="aff">a</xref>
<xref rid="aff2" ref-type="aff">b</xref>
<xref rid="aff3" ref-type="aff">c</xref>
<xref rid="cor1" ref-type="corresp">∗</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>a</label>
Fortis CDOC Hospital for Diabetes and Allied Specialties, Chirag Enclave, New Delhi, India</aff>
<aff id="aff2"><label>b</label>
National Diabetes, Obesity and Cholesterol Foundation, New Delhi, India</aff>
<aff id="aff3"><label>c</label>
Diabetes Foundation (India), New Delhi, India</aff>
<author-notes><corresp id="cor1"><label>∗</label>
Corresponding author. Fortis CDOC Hospital for Diabetes and Allied Specialties, Chirag Enclave, New Delhi, India <email>anoopmisra@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="pmc-release"><day>4</day>
<month>4</month>
<year>2020</year>
</pub-date>
<pmc-comment> PMC Release delay is 0 months and 0 days and was based on .</pmc-comment>
<pub-date pub-type="epub"><day>4</day>
<month>4</month>
<year>2020</year>
</pub-date>
<elocation-id></elocation-id>
<permissions><copyright-statement>© 2020 Published by Elsevier Ltd on behalf of Diabetes India.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder></copyright-holder>
<license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p>
</license>
</permissions>
<abstract id="abs0010"><sec><title>Background and Aims</title>
<p>In view of restrictions on mobility of patients because of COVID-19 pandemic, face-to-face consultations are difficult. We sought to study the feasibility of telemedicine in this scenario.</p>
</sec>
<sec><title>Methods</title>
<p>PubMed database and Google Scholar were searched using the key terms ‘telemedicine’, ‘diabetes’, ‘COVID-19’up to 31<sup>ST</sup>
March 2020. In addition, existing guidelines including those by Ministry of Health and Family Welfare (MOHFW), Government of India were accessed.</p>
</sec>
<sec><title>Results</title>
<p>We discuss evidence and general guidelines regarding role of telemedicine in patients with diabetes along with its utility and limitations.</p>
</sec>
<sec><title>Conclusions</title>
<p>Telemedicine is a useful tool for managing patients of diabetes during this lockdown period. However, there is limited data and further research is required.</p>
</sec>
</abstract>
<abstract abstract-type="author-highlights" id="abs0015"><title>Highlights</title>
<p><list list-type="simple" id="ulist0010"><list-item id="u0010"><label>•</label>
<p id="p0010">Telemedicine could emerge as a viable and effective option for managing patients with diabetes in the lockdown period requiring restrictions of travel.</p>
</list-item>
<list-item id="u0015"><label>•</label>
<p id="p0015">Telemedicine includes a wide array of tools, and the choice depends on physician’s or patient’s ease of handling these tools and available technology.</p>
</list-item>
<list-item id="u0020"><label>•</label>
<p id="p0020">In this article, we state simple principles of telemedicine directed towards management of patients with diabetes.</p>
</list-item>
</list>
</p>
</abstract>
</article-meta>
</front>
</pmc>
<affiliations><list><country><li>Inde</li>
</country>
</list>
<tree><country name="Inde"><noRegion><name sortKey="Ghosh, Amerta" sort="Ghosh, Amerta" uniqKey="Ghosh A" first="Amerta" last="Ghosh">Amerta Ghosh</name>
</noRegion>
<name sortKey="Gupta, Ritesh" sort="Gupta, Ritesh" uniqKey="Gupta R" first="Ritesh" last="Gupta">Ritesh Gupta</name>
<name sortKey="Misra, Anoop" sort="Misra, Anoop" uniqKey="Misra A" first="Anoop" last="Misra">Anoop Misra</name>
<name sortKey="Misra, Anoop" sort="Misra, Anoop" uniqKey="Misra A" first="Anoop" last="Misra">Anoop Misra</name>
<name sortKey="Misra, Anoop" sort="Misra, Anoop" uniqKey="Misra A" first="Anoop" last="Misra">Anoop Misra</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000110 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 000110 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= StressCovidV1 |flux= Pmc |étape= Checkpoint |type= RBID |clé= PMC:7129346 |texte= Telemedicine for Diabetes Care in India during COVID19 Pandemic and National Lockdown Period: Guidelines for Physicians }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i -Sk "pubmed:32283497" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a StressCovidV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |